Breathlessness at rest on a mountain trip is a red-flag symptom, and one of the most important causes to recognize is high-altitude pulmonary edema, usually shortened to HAPE. HAPE is a non-cardiogenic accumulation of fluid in the lungs triggered by exposure to altitude, most often above 2,500 meters, though it can occur lower in susceptible people and is more common with rapid ascent. I have taught altitude illness prevention to trekkers, climbers, and guides, and the pattern is remarkably consistent: someone who was only mildly short of breath while hiking becomes winded while sitting in a tent, develops a dry cough that may turn wet, and starts moving more slowly than everyone else. That change matters because HAPE can progress quickly and become fatal if descent and oxygen are delayed.
Understanding HAPE starts with a clear definition. At altitude, low oxygen causes constriction of blood vessels in the lungs. In some people, that response is exaggerated and uneven, creating high pressure in parts of the pulmonary circulation. Fluid then leaks through capillary walls into the air spaces, reducing oxygen exchange. Unlike pneumonia, HAPE is not caused by infection. Unlike heart failure, it does not begin with a weak heart. It is primarily a pressure-and-permeability problem in the lungs caused by hypoxia. The key early clue is decreased exercise tolerance out of proportion to the terrain or the traveler’s usual fitness, followed by breathlessness at rest, cough, chest tightness, fast heart rate, and low oxygen saturation for the elevation.
This topic matters because HAPE is both preventable and treatable when recognized early. It also overlaps with common mountain complaints, which is why people miss it. A tired trekker may assume they are deconditioned, anxious, or fighting a chest cold. A group may blame the weather, poor sleep, or a heavy pack. Those explanations are dangerous once a person is breathless while resting. The practical question on any mountain trip is not whether someone feels perfect; it is whether they are safe to remain at altitude. On that point, HAPE should be high on the list whenever rest breathing becomes labored, especially after a recent ascent. As the hub page for HAPE, this guide explains symptoms, timing, risk factors, diagnosis in the field, immediate treatment, prevention, and when evacuation is urgent.
What HAPE is and why it develops
HAPE is the most serious lung complication of altitude exposure and one of the three major altitude illnesses, alongside acute mountain sickness and high-altitude cerebral edema. The classic mechanism is hypoxic pulmonary vasoconstriction. When oxygen drops, the lungs narrow blood vessels to redirect flow toward better-ventilated areas. At sea level this can be adaptive. At altitude, especially during rapid ascent, the response can become excessive. Mean pulmonary artery pressure rises, blood flow is unevenly distributed, and mechanical stress damages the capillary barrier. The result is protein-rich fluid leaking into alveoli, causing crackles, impaired gas exchange, and worsening hypoxemia.
In practice, HAPE usually appears within two to five days after ascent to a new sleeping altitude, but timing varies. It often develops after sleeping higher than the body can tolerate, and symptoms commonly worsen overnight. Cold exposure, heavy exertion, and respiratory infections can add stress, but they are not required. I have seen experienced trekkers develop HAPE on itineraries that looked reasonable on paper because they flew from sea level, slept poorly, and then pushed hard on day two. Fitness does not protect against HAPE. In fact, fit travelers sometimes climb too fast because they can tolerate effort while the lungs are quietly deteriorating.
Children can develop HAPE, and recurrent cases occur in people with unusually strong pulmonary vascular responses to hypoxia. Rarely, an underlying problem such as pulmonary hypertension, congenital heart disease, or reduced nitric oxide availability increases susceptibility. Recognized pathophysiology is why treatments work: oxygen raises alveolar oxygen pressure, descent removes the hypoxic trigger, and nifedipine lowers pulmonary artery pressure. These are not comfort measures; they directly address the mechanism of disease.
Symptoms and signs: when breathlessness at rest should alarm you
The symptom progression of HAPE is more useful than any single complaint. Early signs include reduced exercise capacity, unusual fatigue, slower pace, and breathlessness on exertion that is disproportionate to the route. A person who normally chats while walking may stop frequently, avoid small inclines, or lag badly on easy ground. As fluid accumulation worsens, cough appears, often dry at first. Resting heart rate increases. Sleep becomes poor, and the person may wake gasping. The defining escalation is dyspnea at rest: the traveler is short of breath while sitting still, dressing, or speaking in full sentences.
Field signs support the diagnosis. Look for rapid breathing, rapid pulse, bluish lips or fingernails, reduced oxygen saturation compared with companions at the same elevation, and crackles or rales in the lungs, especially over the right middle lobe or both lower fields. Frothy sputum or pink sputum can occur late and signals severe disease. Fever may be absent or low grade; a high fever points more toward infection, although pneumonia and HAPE can coexist. Orthopnea, the need to sit upright to breathe, is another worrying feature. Ataxia, confusion, or severe headache suggest concurrent cerebral involvement, which raises urgency even further.
| Feature | Typical in HAPE | Typical in pneumonia/bronchitis | Typical in anxiety or overexertion |
|---|---|---|---|
| Recent ascent | Usually within 2 to 5 days | Not required | Often yes, but symptoms improve with rest |
| Breathlessness at rest | Common and progressive | Possible | Usually episodic, not steadily worsening |
| Cough | Dry, later wet or frothy | Common, often productive earlier | Uncommon |
| Fever | Absent or mild | Often present | Absent |
| Lung sounds | Crackles, sometimes unilateral early | Focal crackles or wheeze | Usually normal |
| Response to oxygen/descent | Often rapid improvement | Partial only | Rapid if hyperventilation settles |
How to tell HAPE from normal acclimatization and other illnesses
Mild shortness of breath with exertion is normal at altitude. Breathlessness at rest is not. That distinction is the simplest bedside rule. During acclimatization, a healthy person may breathe faster, have lower exercise capacity, and notice periodic breathing during sleep, but they should still be comfortable while sitting quietly. If they cannot lie flat, cannot walk a few steps without stopping, or seem progressively worse after arriving at camp, think beyond ordinary acclimatization.
Acute mountain sickness mainly causes headache, nausea, poor appetite, dizziness, and fatigue. HAPE may occur with or without those symptoms. A person can have minimal headache and still have dangerous lung edema. High-altitude cerebral edema causes altered mental status, severe lassitude, and ataxia; when HAPE and cerebral edema overlap, mortality risk rises sharply unless descent is immediate. Asthma usually presents with wheeze and a personal history, though cold dry air can provoke attacks at altitude. Pulmonary embolism is another serious mimic, especially after prolonged travel, but ascent history and response to oxygen and descent often point toward HAPE in the mountain setting.
Pulse oximetry can help, but it is not definitive. Saturation values naturally fall with altitude and vary by device, temperature, and perfusion. Use trends and comparisons. If one trekker is markedly lower than peers at the same elevation and looks breathless, that supports HAPE. The Wilderness Medical Society and standard expedition medicine teaching emphasize that diagnosis is primarily clinical. You do not need a chest X-ray to act. Waiting for confirmation can waste the safest treatment window.
Who is at highest risk on a mountain trip
The biggest modifiable risk factor is rapid ascent, especially a large jump in sleeping altitude without acclimatization days. Flying to cities such as La Paz, Cusco, or Lhasa and then moving higher immediately is a common setup. Sleeping above 3,000 meters after sea-level travel increases risk, and each additional fast gain compounds the problem. Exertion in the first days at altitude, particularly carrying heavy loads or climbing aggressively, increases pulmonary artery pressure and can unmask susceptibility.
Prior HAPE is one of the strongest predictors of future HAPE. If someone has had it before, their itinerary should be conservative and their prevention plan explicit. Young healthy males appear overrepresented in some mountaineering reports, likely because they ascend rapidly and work hard, but HAPE can affect any age and sex. Viral respiratory infections may lower the threshold. Cold exposure may contribute through sympathetic activation and pulmonary vasoconstriction. Children living at altitude can develop a related syndrome on re-entry after time at low elevation, a pattern described in high Andean populations.
Medication and physiology matter too. People with known pulmonary hypertension, certain congenital heart defects, or reduced ventilatory responses need specialist pre-trip advice. There is ongoing study of genetic influences involving endothelial function, nitric oxide, and ion transport, but practical screening remains history based. If a traveler says, “I always get chest symptoms when I go high,” treat that seriously. In expedition planning, risk is managed by ascent profile more than by confidence or prior athletic achievement.
Immediate treatment: what to do first
When HAPE is suspected, stop ascent immediately. Do not send the person higher “to see if they settle in.” The first-line treatment is descent, ideally at least 500 to 1,000 meters, and farther if symptoms do not improve quickly. Supplemental oxygen is highly effective and should be given whenever available, titrated to relieve distress and improve saturation. In many cases, a person who looks critically unwell improves within minutes on oxygen, but that improvement does not mean they are safe to remain high. They still need descent unless medical care confirms stability at a lower-risk altitude.
If descent is delayed by storm, darkness, terrain, or limited staffing, use a portable hyperbaric bag if your team has one. Devices such as the Gamow bag or Certec bag simulate descent by increasing ambient pressure around the patient. They buy time; they do not replace evacuation. Keep the patient warm, minimize exertion, and assign companions to monitor breathing, mental status, urine output, and response to therapy. Avoid leaving the patient alone in a tent. If the person also has signs of cerebral edema, dexamethasone may be added for the neurologic component, but it is not the primary drug for isolated HAPE.
Nifedipine is the best established medication adjunct for HAPE because it lowers pulmonary artery pressure. Extended-release nifedipine is commonly used in wilderness protocols when oxygen or descent is limited or when the diagnosis is strongly suspected. Phosphodiesterase-5 inhibitors such as tadalafil or sildenafil have supporting evidence mainly in prevention and selected treatment contexts, but they are not substitutes for descent. Diuretics such as furosemide are generally avoided unless another diagnosis clearly warrants them; the problem is not fluid overload, and volume depletion can worsen altitude illness management.
Prevention, trip planning, and safe return to altitude
The most reliable prevention strategy is a gradual ascent profile. Above about 3,000 meters, increase sleeping altitude slowly and insert rest or acclimatization days on longer itineraries. Many clinicians use the practical rule of limiting sleeping elevation gain to around 300 to 500 meters per night once above that threshold, with an extra night every few days. “Climb high, sleep low” can help, but it does not cancel the risks of an overly aggressive schedule. Trek companies that build realistic acclimatization into the itinerary consistently reduce serious altitude problems.
For travelers with prior HAPE, prophylaxis deserves individual planning. Nifedipine extended release has the strongest track record for prevention in known susceptible people. Tadalafil is another option in some protocols. Acetazolamide is excellent for acclimatization and acute mountain sickness prevention, but it is not the primary preventive medication for HAPE, so travelers should not assume it covers every altitude risk. Pre-trip discussion should review prior episodes, maximum sleeping altitude, access to oxygen, communication systems, evacuation logistics, and the guide team’s training. I advise clients to define a turnaround and descent threshold before the trip begins, because clear decisions made at home are easier to follow on a cold mountain evening.
Returning to altitude after HAPE requires caution. The person should not re-ascend until symptoms have fully resolved and oxygenation is normal for the new elevation. Any re-ascent should be slower than the one that triggered illness. Recurrent episodes warrant formal cardiopulmonary evaluation after the trip, sometimes including echocardiography or assessment for pulmonary hypertension. The main benefit of understanding HAPE is simple: when breathlessness at rest appears, you can act fast, descend early, and prevent a reversible problem from becoming a fatal one. If you are planning a high-altitude trip, build acclimatization into your route, carry a clear treatment plan, and treat unexplained rest breathlessness as an emergency until proven otherwise.
Frequently Asked Questions
What is HAPE, and why is breathlessness at rest on a mountain trip such a serious warning sign?
High-altitude pulmonary edema, or HAPE, is a dangerous form of altitude illness in which fluid builds up in the lungs after exposure to altitude. It is called “non-cardiogenic” because the fluid is not caused by heart failure. Instead, low oxygen at altitude triggers abnormal narrowing of blood vessels in the lungs, which raises pressure in the pulmonary circulation. That pressure can force fluid into the air spaces, making it harder and harder to oxygenate the blood. The result is escalating shortness of breath, reduced exercise tolerance, fatigue, and eventually severe oxygen deprivation if the person remains at altitude.
Breathlessness at rest matters because it is not a normal response to being a bit deconditioned, tired, or “just not great at altitude.” Many travelers notice they get winded on steep climbs, but if someone feels short of breath while sitting still, lying down, or doing minimal activity, that should be treated as a red-flag symptom. In the mountain setting, HAPE belongs high on the list of possibilities, especially if the person has recently ascended, is above roughly 2,500 meters, or is worsening over hours rather than improving with rest.
One of the most important practical points is that HAPE often begins subtly. A person may first notice unusually poor performance, slower pace, lingering cough, or trouble keeping up with a group. Then the breathing becomes labored even during easy walking, and eventually at rest. Recognizing that pattern early can prevent a true emergency. Left untreated, HAPE can progress to life-threatening respiratory failure, so any breathlessness at rest during a mountain trip should be taken seriously until proved otherwise.
What are the early symptoms and classic signs of HAPE that travelers, trekkers, and guides should watch for?
The classic pattern of HAPE is a recent ascent followed by a steady decline in breathing and performance. Early symptoms often include unusual shortness of breath with exertion, fatigue that seems out of proportion to the day’s effort, reduced ability to keep up, and a dry cough. Many people describe a strong sense that something is off: they are more exhausted than expected, need frequent stops, or feel as though their lungs are not recovering normally after even mild activity.
As HAPE progresses, the warning signs become more obvious. Breathlessness starts happening with lighter effort and then at rest. The cough may worsen and can become productive, sometimes with frothy sputum. A person may have chest tightness, rapid breathing, rapid heart rate, marked weakness, and difficulty sleeping because lying flat makes breathing feel worse. On observation, they may look pale, exhausted, anxious, or slightly blue around the lips or fingernails if oxygen levels are falling significantly.
On examination, a trained clinician may hear crackles in the lungs, often beginning in one area and then spreading. Oxygen saturation is usually lower than expected for the altitude, though pulse oximeters can vary and should support, not replace, clinical judgment. Importantly, HAPE may occur along with other altitude illnesses, including acute mountain sickness or high-altitude cerebral edema, which means confusion, poor coordination, or altered behavior are especially alarming. In real mountain settings, the key clue is worsening respiratory distress after ascent, particularly when the person is no longer just breathless on exertion but is clearly short of breath at rest.
At what altitude can HAPE happen, and who is most at risk for developing it?
HAPE is most commonly associated with altitudes above 2,500 meters, but that number is not an absolute rule. Susceptible people can develop it at somewhat lower elevations, while others remain well much higher. The biggest risk factor is rapid ascent without adequate time to acclimatize. When someone goes from low altitude to sleeping much higher in a short period, especially over one to three days, the lungs may respond poorly to the reduced oxygen environment.
Other important risk factors include a prior history of HAPE, which strongly increases future risk, intense exertion soon after arrival at altitude, cold exposure, and possibly respiratory infections that stress the lungs. Some people appear biologically more susceptible because of the way their pulmonary blood vessels respond to low oxygen. That is why HAPE can occasionally occur in young, fit, highly motivated trekkers or climbers who assume their fitness will protect them. Physical fitness does not prevent altitude illness.
Group leaders should be especially alert in situations that combine fast ascent, high sleeping altitude, and social pressure to continue. Examples include driving quickly to a high trailhead, flying into a mountain town and starting hard trekking immediately, or pushing on despite a new cough and falling pace. HAPE can also affect children and adults who are otherwise healthy. If there is a previous episode of HAPE, a recent large altitude jump, or unexplained respiratory decline after ascent, suspicion should be high even if the person is not extremely high on the mountain.
How can you tell the difference between HAPE and normal altitude breathlessness, a chest infection, or simple exhaustion?
This is one of the most important questions because early HAPE is often misread as fatigue, poor fitness, overexertion, or “just the altitude.” Mild breathlessness during uphill movement is common at elevation, but normal altitude adjustment should not cause persistent shortness of breath while resting. A useful practical distinction is trajectory: normal exertional breathlessness improves fairly quickly when the person stops, while HAPE tends to worsen over time and begins to interfere with easy walking, routine camp tasks, and eventually quiet rest.
A chest infection can overlap with HAPE because both may involve cough, fatigue, and shortness of breath. However, HAPE often follows recent ascent and typically causes a disproportionate drop in exercise capacity and oxygenation relative to any cold symptoms. Fever may point more toward infection, but its absence does not rule out infection, and mild fever can occasionally occur in altitude illness too. In the mountains, if a person has a cough plus deteriorating breathing after ascent, it is safer to consider HAPE seriously rather than assume it is “just bronchitis.”
Simple exhaustion usually improves with food, fluids, warmth, and rest. HAPE does not reliably do that. The person may continue to look unwell, breathe rapidly, and struggle to recover even after stopping. They may become breathless putting on boots, speaking in long sentences, or walking a few steps. If a pulse oximeter is available, an unexpectedly low reading for the altitude can support suspicion, but a normal or borderline reading should not create false reassurance if the clinical picture is concerning.
The bottom line is this: on a mountain trip, worsening breathlessness after ascent, especially breathlessness at rest, should be treated as HAPE until assessed otherwise. It is far better to overreact early than to miss a condition that can deteriorate quickly.
What should you do immediately if you suspect HAPE during a mountain trip?
If HAPE is suspected, the priority is to stop ascent immediately. The person should not be encouraged to “push through” to the next camp or summit. Continued ascent can rapidly worsen the condition. The most important treatment is descent, and it should happen as soon as it is feasible and safe. Even a descent of several hundred meters can make a meaningful difference, though more may be needed depending on severity and location.
Supplemental oxygen, if available, is extremely helpful and can be lifesaving. It improves oxygen levels and reduces stress on the lungs while descent is being arranged or carried out. Rest, warmth, and minimizing exertion also matter because physical effort increases oxygen demand and can worsen symptoms. If the patient is too breathless to walk safely, they should be assisted, evacuated, or transported if possible. In some expedition settings, a portable hyperbaric bag may be used when descent is temporarily impossible, but it is a bridge measure, not a substitute for getting lower.
Medication may have a role, especially nifedipine in known or suspected HAPE when guided by a clinician or trained protocol, but drugs should never delay descent. Because other serious conditions can mimic or accompany HAPE, medical assessment is important as soon as possible. Anyone with severe breathlessness, blue lips, confusion, inability to walk safely, decreasing responsiveness, or obvious respiratory distress needs urgent evacuation and emergency care.
The biggest mistake is delay. People often wait because they hope the person will improve overnight, or they do not want to disrupt the itinerary. That hesitation can be dangerous. When someone on a mountain trip develops breathlessness at rest after ascent, the safest mindset is to act early, descend promptly, and treat the situation as potentially serious until proven otherwise.
